Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal epithelial surface and the overlying tear film constitute a complex, integrated functional unit essential for maintaining ocular health and visual clarity (StatPearls, 2023). The tear film is a dynamic structure composed of an outer lipid layer, a middle aqueous layer, and an inner mucin layer that interacts with the corneal glycocalyx to provide a smooth refractive surface and lubricate the ocular surface (NIH, 2023). The corneal epithelium acts as a physical and immunological barrier, utilizing tight junctions to prevent the entry of pathogens and environmental toxins into the deeper corneal layers (PubMed, 2021). Dysfunction of this interface, often characterized by tear film instability or hyperosmolarity, is the hallmark of dry eye disease, leading to chronic inflammation and potential epithelial damage (TFOS DEWS II, 2017). Therapeutic strategies targeting this system include the use of lubricants to supplement tear volume, lipid-based emulsions to reduce evaporation, and anti-inflammatory agents like cyclosporine to address the underlying immune-mediated damage to the ocular surface (PubMed, 2022). Additionally, newer treatments like perfluorohexyloctane focus specifically on stabilizing the lipid layer to prevent excessive tear evaporation.
Lubrication, tear film stabilization, reduction of evaporation, osmoprotection, and inhibition of T-cell mediated inflammation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal epithelial surface and tear film.